tiprankstipranks
Trending News
More News >
New Horizon Health Limited (HK:6606)
:6606
Hong Kong Market

New Horizon Health Limited (6606) Ratios

Compare
2 Followers

New Horizon Health Limited Ratios

HK:6606's free cash flow for Q2 2023 was ¥0.91. For the 2023 fiscal year, HK:6606's free cash flow was decreased by ¥ and operating cash flow was ¥-0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
8.80 10.65 4.47 4.63-
Quick Ratio
8.49 10.34 4.43 4.58-
Cash Ratio
4.97 3.55 2.89 3.51-
Solvency Ratio
-0.12 -13.59 -0.41 -0.10-
Operating Cash Flow Ratio
-1.81 -1.83 -0.84 -0.76-
Short-Term Operating Cash Flow Coverage
0.00 -4.46 -1.88 -5.59-
Net Current Asset Value
¥ 1.55B¥ 1.83B¥ -1.21B¥ -454.70M-
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.05 0.18 0.15-
Debt-to-Equity Ratio
0.12 0.06 -0.14 -0.23-
Debt-to-Capital Ratio
0.10 0.05 -0.16 -0.29-
Long-Term Debt-to-Capital Ratio
0.08 0.00 -0.04 -0.11-
Financial Leverage Ratio
1.21 1.11 -0.75 -1.49-
Debt Service Coverage Ratio
-6.33 -35.29 -9.83 -6.27-
Interest Coverage Ratio
-21.68 -394.98 -98.96 -82.04-
Debt to Market Cap
0.03 0.01 <0.01 <0.01-
Interest Debt Per Share
0.61 0.35 0.38 0.20-
Net Debt to EBITDA
19.28 0.18 0.39 2.88-
Profitability Margins
Gross Profit Margin
84.47%72.68%52.79%58.89%-
EBIT Margin
-9.45%-1446.49%-1106.30%-180.15%-
EBITDA Margin
-6.01%-1437.44%-1085.23%-157.20%-
Operating Profit Margin
-20.87%-1440.41%-1084.73%-176.11%-
Pretax Profit Margin
-10.41%-1450.14%-1117.27%-182.30%-
Net Profit Margin
-10.36%-1459.87%-1117.70%-182.69%-
Continuous Operations Profit Margin
-10.50%-1450.14%-1117.70%-182.69%-
Net Income Per EBT
99.47%100.67%100.04%100.22%-
EBT Per EBIT
49.91%100.68%103.00%103.51%-
Return on Assets (ROA)
-3.08%-131.95%-96.42%-19.49%-
Return on Equity (ROE)
-3.73%-146.05%72.37%29.12%-
Return on Capital Employed (ROCE)
-6.80%-141.85%-115.72%-22.93%-
Return on Invested Capital (ROIC)
-6.80%-137.05%-103.39%-21.95%-
Return on Tangible Assets
-3.10%-132.97%-98.83%-20.19%-
Earnings Yield
-1.47%-45.59%-2.67%-0.34%-
Efficiency Ratios
Receivables Turnover
1.31 2.01 2.18 3.26-
Payables Turnover
2.77 2.46 3.89 3.57-
Inventory Turnover
1.68 0.99 5.44 5.08-
Fixed Asset Turnover
5.51 2.08 0.97 0.86-
Asset Turnover
0.30 0.09 0.09 0.11-
Working Capital Turnover Ratio
0.42 0.18 0.16 0.35-
Cash Conversion Cycle
363.43 403.99 141.05 81.60-
Days of Sales Outstanding
278.70 181.84 167.68 112.02-
Days of Inventory Outstanding
216.73 370.33 67.15 71.90-
Days of Payables Outstanding
132.00 148.17 93.79 102.32-
Operating Cycle
495.43 552.16 234.84 183.92-
Cash Flow Ratios
Operating Cash Flow Per Share
-0.99 -0.94 -0.32 -0.18-
Free Cash Flow Per Share
-1.12 -1.03 -0.37 -0.27-
CapEx Per Share
0.13 0.10 0.06 0.09-
Free Cash Flow to Operating Cash Flow
1.13 1.10 1.18 1.49-
Dividend Paid and CapEx Coverage Ratio
-7.66 -9.56 -5.50 -2.04-
Capital Expenditure Coverage Ratio
-7.66 -9.56 -5.50 -2.04-
Operating Cash Flow Coverage Ratio
-1.68 -2.88 -0.88 -0.90-
Operating Cash Flow to Sales Ratio
-0.54 -1.67 -1.87 -1.29-
Free Cash Flow Yield
-8.03%-5.75%-0.53%-0.36%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-68.13 -2.19 -37.45 -294.57-
Price-to-Sales (P/S) Ratio
7.59 32.02 418.56 538.17-
Price-to-Book (P/B) Ratio
2.54 3.20 -27.10 -85.79-
Price-to-Free Cash Flow (P/FCF) Ratio
-12.46 -17.39 -188.90 -280.60-
Price-to-Operating Cash Flow Ratio
-13.09 -19.21 -223.25 -418.23-
Price-to-Earnings Growth (PEG) Ratio
-0.68 >-0.01 -0.06 5.49-
Price-to-Fair Value
2.54 3.20 -27.10 -85.79-
Enterprise Value Multiple
-107.09 -2.04 -38.17 -339.48-
Enterprise Value
4.92B 6.25B 29.23B 31.10B-
EV to EBITDA
-107.13 -2.04 -38.17 -339.48-
EV to Sales
6.44 29.37 414.27 533.65-
EV to Free Cash Flow
-10.56 -15.95 -186.97 -278.25-
EV to Operating Cash Flow
-11.94 -17.62 -220.96 -414.71-
Tangible Book Value Per Share
5.03 5.57 -2.66 -0.92-
Shareholders’ Equity Per Share
5.09 5.62 -2.61 -0.87-
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01-
Revenue Per Share
1.83 0.56 0.17 0.14-
Net Income Per Share
-0.19 -8.21 -1.89 -0.25-
Tax Burden
0.99 1.01 1.00 1.00-
Interest Burden
1.10 1.00 1.01 1.01-
Research & Development to Revenue
0.12 0.28 0.36 0.45-
SG&A to Revenue
0.21 0.60 1.47 0.25-
Stock-Based Compensation to Revenue
0.09 0.11 0.21 0.18-
Income Quality
5.21 0.11 0.17 0.71-
Currency in CNY